Amy C. Peterson Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Amy C. Peterson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Amy C. Peterson. Amy C. Peterson is a EVP, Chief Development Officer in CytomX Therapeutics, Inc. ($CTMX) and a CMO, Immuno-oncology in BeiGene, Ltd. ($BGNE).
Address: C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN KY1-1108Cayman Islands
Companies in which Amy C. Peterson is an Insider
BeiGene, Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amy C. Peterson: CMO, Immuno-oncology
Holdings: 9,859 shares
Current Value: $354,135
Latest Transaction: Dec 19 2018
$BGNE Market Capitalization: $1.14B
$BGNE Previous Close: $35.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CytomX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Amy C. Peterson: EVP, Chief Development Officer
Holdings: 3,101 shares
Current Value: $35,662
Latest Transaction: Mar 02 2021
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Amy C. Peterson
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2021 | CTMX | CytomX Therapeutic ... | Peterson Amy C. | EVP, Chief Developm ... | Option Exercise | A | 7.85 | 250,000 | 1,962,500 | 250,000 | |
| Dec 07 2020 | CTMX | CytomX Therapeutic ... | Peterson Amy C. | EVP, Chief Developm ... | Grant | A | 6.39 | 3,101 | 19,822 | 3,101 | 0 to 3.1 K |
| Feb 19 2020 | CTMX | CytomX Therapeutic ... | Peterson Amy C. | EVP, Chief Developm ... | Option Exercise | A | 7.13 | 25,000 | 178,250 | 25,000 | |
| Oct 16 2019 | CTMX | CytomX Therapeutic ... | Peterson Amy C. | EVP, Chief Developm ... | Option Exercise | A | 7.16 | 400,000 | 2,864,000 | 400,000 | |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Option Exercise | M | 2.24 | 131,833 | 295,306 | 820,000 | |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Option Exercise | M | 2.24 | 128,167 | 287,094 | 951,833 | |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 135.54 | 611 | 82,816 | 0 | 611 to 0 (-100.00 %) |